Stronger Sell Today ADMP ranks #3881 as SELL CANDIDATE #3881 Weaker Sell

ADMP stock forecast Adamis Pharmaceuticals Corporation

ADMP stock forecast





ADMP Forecast and Technical Stock Analysis

Sell candidate since 2019-07-16 Loss -8.59%

Adamis Pharmaceuticals Corporation fell by -7.87% in the last day ( Friday, 19th Jul 2019 ) from $1.27 to $1.17 During day the stock fluctuated 9.56% from a day low at $1.17 to a day high of $1.28. The price has been going up and down for this period, and there has been a -8.59% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -559 638 shares and in total 512 412 shares bought and sold for approximately $599 522.00.

Quick summary:

  • 30 day high of the ADMP stock price was $1.57 and low was $1.17.
  • 90 day high was $2.32 and low was $1.17.
  • 52 week high for the Adamis Pharmaceuticals Corporation - $4.25 and low - $1.17.
Top Trending Stocks


Adamis Pharmaceuticals Corporation lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.68% during the next 3 months and, with 90% probability hold a price between $0.50 and $0.91 at the end of this period.

Top Golden Star Stocks


There are few to none technical positive signals at the moment. Adamis Pharmaceuticals Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.32 and $1.35. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday July 15, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 42 and the stock is currently not being overbought or oversold

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $1.17 Resistance: $1.27


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 9.56%. For the last week the stock has had a daily average volatility of 10.23%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

10.23 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded


Adamis Pharmaceuticals Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today ADMP ranks #3881 as SELL CANDIDATE #3881 Weaker Sell

Will ADMP stock price go up or down on Mon, 22 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at